徐进 - 华东师范大学 - 经济与管理学部

个人简介

华东师范大学统计学院教授。2004年美国鲍林格林大学博士，2004-2005年加利福尼亚大学河边分校博士后。2005-2006年Ambion 生物统计师。2006年5月起华东师范大学任教至今。工作经历 2004-2005年，加利福尼亚大学河边分校博士后 2005-2006年，Ambion 生物统计师 2006年-，华东师范大学教育经历华东师范大学，本科，1999年美国鲍林格林大学，博士，2004年

研究领域

临床试验，生物统计，多元分析

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Dufera,A., Xiong,C., and Xu,J. (2023) Simultaneous confidence intervals from randomization tests with application in testing bioequivalence with multiple endpoints, Biometrical Journal, 65, 2200082. Dufera,A., Liu,T., and Xu,J. (2023) Regression models of Pearson correlation coefficient, Statistical Theory and Related Fields, 7, 97-106. Ditzhaus,M., Yu,M., and Xu,J. (2023) Studentized permutation method for comparing restricted mean survival times with small sample from randomized trials, Statistics in Medicine, 42, 2226-2240. Dormuth,I., Liu,T., Xu,J., Pauly,M., and Ditzhaus,M. (2023) A comparative study to alternatives to the log-rank test, Contemporary Clinical Trials, 128, 107165. Zhang,D. and Xu,J. (2023) A Bayesian design for finding optimal biological dose with mixed types of responses of toxicity and efficacy, Contemporary Clinical Trials, 127, 107203. Xu,J., Zhang,D., and Mu,R. (2022) A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation, BMC Medical Research Methodology, 22, 258. Bizuayehu,S.B. and Xu,J. (2022) Model-free screening for variables with treatment interaction, Statistical Methods in Medical Research, 31, 1845-1859. Bizuayehu,S.B., Li,L., and Xu,J. (2022) Variable screening in multivariate linear regression with high dimensional covariates, Statistical Theory and Related Fields, 6, 241-253. Belay,S.Y., Guo,X., Lin,X., Xia,F., and Xu,J. (2022) Bayesian basket trial design accounting for multiple cutoffs of an ambiguous biomarker, Statistics in Biopharmaceutical Research, 143, 342-348. Dormuth,I., Liu,T., Xu,J., Yu,M., Pauly,M., and Ditzhaus,M. (2022) Which test for crossing survival curves? A user’s guideline, BMC Medical Research Methodology, 22, 34. Mu,R., Xu,J., Tang,R., Kopetz,S., and Yuan,Y. (2022) A Bayesian phase I/II platform design for co-developing drug combination therapies for multiple indications, Statistics in Medicine, 41, 374-389. Adall,S.W. and Xu,J. (2021) Bayesian shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trial, Pharmaceutical Statistics, 20, 1074-1087. Liu,T., Chen,Z., and Xu,J. (2021) Epidemiological characteristics and incubation period of SARS-CoV-2 during the 2020-2021 winter pandemic wave in North China: an observational study, Journal of Medical Virology, 93, 6628-6633. Belay,S.Y., Mu,R., and Xu,J. (2021) A Bayesian biosimilar trial design with time-to-event endpoint, Pharmaceutical Statistics, 20, 597-609. Xu,J., Mu,R. and Xiong,C. (2021) A Bayesian stochastic approximation method, Journal of Statistical Planning and Inference, 211, 391-401. Huang,X. and Xu,J. (2020) Estimating individualized treatment rules with risk constraint, Biometrics, 76, 1310-1318. Liu,T., Ditzhaus,M., and Xu,J. (2020) A resampling-based test for two crossing survival curves, Pharmaceutical Statistics, 19, 399-409. Huang,X., Goldberg,Y. and Xu,J. (2019) Multi-category individualized treatment regime using outcome weighted learning, Biometrics, 75, 1216-1227. Mu,R., Yuan,Y., Xu,J., Mandrekar,S.J. and Yin,J. (2019) gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points, Journal of the Royal Statistical Society Series C, 68, 289-308.